Literature DB >> 20924632

Myotonic dystrophies as a brain disorder.

Giovanni Meola1.   

Abstract

Entities:  

Mesh:

Year:  2010        PMID: 20924632     DOI: 10.1007/s10072-010-0414-2

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


× No keyword cloud information.
  7 in total

1.  Reduced cerebral blood flow and impaired visual-spatial function in proximal myotonic myopathy.

Authors:  G Meola; V Sansone; D Perani; A Colleluori; S Cappa; M Cotelli; F Fazio; C A Thornton; R T Moxley
Journal:  Neurology       Date:  1999-09-22       Impact factor: 9.910

2.  Cognitive impairment in adult myotonic dystrophies: a longitudinal study.

Authors:  V Sansone; S Gandossini; M Cotelli; M Calabria; O Zanetti; G Meola
Journal:  Neurol Sci       Date:  2007-03       Impact factor: 3.307

3.  Retrospective study on PET-SPECT imaging in a large cohort of myotonic dystrophy type 1 patients.

Authors:  Vincenzo Romeo; E Pegoraro; F Squarzanti; G Sorarù; C Ferrati; M Ermani; P Zucchetta; F Chierichetti; C Angelini
Journal:  Neurol Sci       Date:  2010-09-15       Impact factor: 3.307

Review 4.  Cerebral involvement in myotonic dystrophies.

Authors:  Giovanni Meola; Valeria Sansone
Journal:  Muscle Nerve       Date:  2007-09       Impact factor: 3.217

5.  Executive dysfunction and avoidant personality trait in myotonic dystrophy type 1 (DM-1) and in proximal myotonic myopathy (PROMM/DM-2).

Authors:  G Meola; V Sansone; D Perani; S Scarone; S Cappa; C Dragoni; E Cattaneo; M Cotelli; C Gobbo; F Fazio; G Siciliano; M Mancuso; E Vitelli; S Zhang; R Krahe; R T Moxley
Journal:  Neuromuscul Disord       Date:  2003-12       Impact factor: 4.296

6.  Glucose metabolism and dopamine PET correlates in a patient with myotonic dystrophy type 2 and parkinsonism.

Authors:  V Sansone; G Meola; D Perani; F Fazio; V Garibotto; M Cotelli; M Cotelli; E Vitelli
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-03       Impact factor: 10.154

Review 7.  Myotonic dystrophy: RNA-mediated muscle disease.

Authors:  Thurman M Wheeler; Charles A Thornton
Journal:  Curr Opin Neurol       Date:  2007-10       Impact factor: 5.710

  7 in total
  5 in total

1.  Diagnostic odyssey of patients with myotonic dystrophy.

Authors:  James E Hilbert; Tetsuo Ashizawa; John W Day; Elizabeth A Luebbe; William B Martens; Michael P McDermott; Rabi Tawil; Charles A Thornton; Richard T Moxley
Journal:  J Neurol       Date:  2013-06-27       Impact factor: 4.849

2.  RAN Translation Regulated by Muscleblind Proteins in Myotonic Dystrophy Type 2.

Authors:  Tao Zu; John D Cleary; Yuanjing Liu; Monica Bañez-Coronel; Jodi L Bubenik; Fatma Ayhan; Tetsuo Ashizawa; Guangbin Xia; H Brent Clark; Anthony T Yachnis; Maurice S Swanson; Laura P W Ranum
Journal:  Neuron       Date:  2017-09-13       Impact factor: 17.173

Review 3.  Repeat-associated non-AUG (RAN) translation: insights from pathology.

Authors:  Monica Banez-Coronel; Laura P W Ranum
Journal:  Lab Invest       Date:  2019-03-27       Impact factor: 5.662

Review 4.  CELFish ways to modulate mRNA decay.

Authors:  Irina Vlasova-St Louis; Alexa M Dickson; Paul R Bohjanen; Carol J Wilusz
Journal:  Biochim Biophys Acta       Date:  2013-01-15

Review 5.  Myotonic Dystrophies: State of the Art of New Therapeutic Developments for the CNS.

Authors:  Genevieve Gourdon; Giovanni Meola
Journal:  Front Cell Neurosci       Date:  2017-04-20       Impact factor: 5.505

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.